Molecular and Immune Signatures, and Pathological Trajectories of Fatal Covid-19 Lungs Defined by in Situ Spatial Single-Cell Transcriptome Analysis
Arun K. Das(Michigan Medicine), Shou‐Jiang Gao(UPMC Hillman Cancer Center), Yu‐Chiao Chiu(The University of Texas at San Antonio Health Science Center), Clare Bryce(Icahn School of Medicine at Mount Sinai), Suzane Ramos da Silva(University of Pittsburgh), Zachary M. Grimes(Mount Sinai Health System), Karla Paniagua Rivera(The University of Texas at San Antonio), Yufei Huang(The University of Texas at San Antonio), Mario Flores(Harvard University), Emilia Mia Sordillo(Icahn School of Medicine at Mount Sinai), Carlos Cordon‐Cardo(Icahn School of Medicine at Mount Sinai), Hugh Galloway(University of Pittsburgh), Luping Chen(University of Pittsburgh), Wen Meng(Central South University), Zhentao Liu(UPMC Hillman Cancer Center), Alberto Paniz‐Mondolfi(Incubadora Venezolana de la Ciencia), Md Musaddaqul Hasib(University of Pittsburgh), Gabriel Sica(Emory University)
Cited by 4
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899